Concomitant Use of NSAIDs or SSRIs with NOACs Requires Monitoring for Bleeding

PURPOSE: Non-vitamin K antagonist oral anticoagulants (NOACs) are widely used in patients with atrial fibrillation (AF) because of their effectiveness in preventing stroke and their better safety, compared with warfarin. However, there are concerns for an increased risk of bleeding associated with c...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Min-Taek, Park, Kwang-Yeol, Kim, Myo-Song, You, Seung-Hun, Kang, Ye-Jin, Jung, Sun-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471076/
https://www.ncbi.nlm.nih.gov/pubmed/32882758
http://dx.doi.org/10.3349/ymj.2020.61.9.741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471076/
https://www.ncbi.nlm.nih.gov/pubmed/32882758
http://dx.doi.org/10.3349/ymj.2020.61.9.741

Ejemplares similares